Recommended strategies for investigating cytochrome P450 contributions on the candidate metabolism at drug discovery stage: appilications for the reaction phenotyping

被引：0
|
作者：
Emoto, Chie [1 ]
Murayama, Norie [1 ]
Rostami-Hodjegan, Amin [2 ]
Yamazaki, Hiroshi [1 ]
机构：
[1] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Tokyo, Japan
[2] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester, Lancs, England
来源：
DRUG METABOLISM REVIEWS | 2011年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [41] Evaluation of Cytochrome P450 Selectivity for Hydralazine as an Aldehyde Oxidase Inhibitor for Reaction Phenotyping
    Yang, Xin
    Johnson, Nathaniel
    Di, Li
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 108 (04) : 1627 - 1630
  • [42] Cytochrome p450 and diseases: Implications in drug metabolism and pathophysiology - Preface
    Pichette, V
    CURRENT DRUG METABOLISM, 2004, 5 (03)
  • [43] Predictive modeling of cytochrome P450 mediated drug metabolism.
    Ewing, T
    Wu, J
    Kocher, JP
    Korzekwa, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U458 - U458
  • [44] Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism -: Focus on in vitro studies
    Donato, MT
    Castell, JV
    CLINICAL PHARMACOKINETICS, 2003, 42 (02) : 153 - 178
  • [45] Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes
    Streetman, DS
    Bertino, JS
    Nafziger, AN
    PHARMACOGENETICS, 2000, 10 (03): : 187 - 216
  • [46] Assessment of Cytochrome P450 Enzyme Inhibition and Inactivation in Drug Discovery and Development
    Nettleton, David O.
    Einolf, Heidi J.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (04) : 382 - 403
  • [47] Evaluation of Strategies for the Assessment of Drug–Drug Interactions Involving Cytochrome P450 Enzymes
    Jelle Reinen
    Martijn Smit
    Mira Wenker
    European Journal of Drug Metabolism and Pharmacokinetics, 2018, 43 : 737 - 750
  • [48] In Vitro Evaluation of Potential Drug-Drug Interactions with Ticagrelor: Cytochrome P450 Reaction Phenotyping, Inhibition, Induction, and Differential Kinetics
    Zhou, Diansong
    Andersson, Tommy B.
    Grimm, Scott W.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (04) : 703 - 710
  • [49] In Vitro Techniques to Study Drug-Drug Interactions of Drug Metabolism: Cytochrome P450
    Houston, J. Brian
    Galetin, Aleksandra
    ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, 2010, : 169 - 215
  • [50] Assessing Cytochrome P450 and UDP-Glucuronosyltransferase Contributions to Warfarin Metabolism in Humans
    Miller, Grover P.
    Jones, Drew R.
    Sullivan, Shane Z.
    Mazur, Anna
    Owen, Suzanne N.
    Mitchell, Neil C.
    Radominska-Pandya, Anna
    Moran, Jeffery H.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2009, 22 (07) : 1239 - 1245
12345